Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
Authors
Keywords
-
Journal
Journal of the American Heart Association
Volume 9, Issue 13, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2020-06-15
DOI
10.1161/jaha.120.017559
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients with Acute Venous Thromboembolism
- (2020) James C. Coons et al. PHARMACOTHERAPY
- Select Drug-Drug Interactions With Direct Oral Anticoagulants
- (2020) Barbara S. Wiggins et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
- (2020) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rates of Potentially Inappropriate Dosing of Direct‐Acting Oral Anticoagulants and Associations With Geriatric Conditions Among Older Patients With Atrial Fibrillation: The SAGE‐AF Study
- (2020) Saket Sanghai et al. Journal of the American Heart Association
- Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
- (2019) Alok A. Khorana et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
- (2019) Renato D. Lopes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anticoagulation Strategies in Patients With Cancer
- (2019) Ramya C. Mosarla et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight
- (2019) So-Ryoung Lee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy and Safety of Apixaban versus Warfarin in Patients with Atrial Fibrillation and Prior Bioprosthetic Valve Replacement or Valve Repair: Insights from the ARISTOTLE Trial
- (2019) Patricia O. Guimarães et al. CLINICAL CARDIOLOGY
- Synergy of Dual Pathway Inhibition in Chronic Cardiovascular Disease
- (2019) Michiel Coppens et al. CIRCULATION RESEARCH
- Clinical Outcomes of Off-Label Dosing of Direct Oral Anticoagulant Therapy Among Japanese Patients With Atrial Fibrillation Identified From the SAKURA AF Registry
- (2019) Nobuhiro Murata et al. CIRCULATION JOURNAL
- Effectiveness and Safety of Rivaroxaban Versus Warfarin in Nonvalvular Atrial Fibrillation Patients with Severe Kidney Disease or Undergoing Hemodialysis
- (2019) Craig I. Coleman et al. AMERICAN JOURNAL OF MEDICINE
- Direct Oral Anticoagulants in Chronic Liver Disease
- (2019) Taylor D. Steuber et al. ANNALS OF PHARMACOTHERAPY
- Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data
- (2019) Margarita Kushnir et al. Lancet Haematology
- Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease
- (2019) Satoshi Yasuda et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anticoagulation in Concomitant Chronic Kidney Disease and Atrial Fibrillation
- (2019) Shankar Kumar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial
- (2019) Robert D. McBane et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States
- (2018) Konstantinos C. Siontis et al. CIRCULATION
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- Pharmacological properties of betrixaban
- (2018) Menno V Huisman et al. EUROPEAN HEART JOURNAL SUPPLEMENTS
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
- (2018) Annie M. Young et al. JOURNAL OF CLINICAL ONCOLOGY
- Direct Oral Anticoagulant Agents: Pharmacologic Profile, Indications, Coagulation Monitoring, and Reversal Agents
- (2018) Deborah K. Rose et al. Journal of Stroke & Cerebrovascular Diseases
- Oral Anticoagulation in Patients With Liver Disease
- (2018) Arman Qamar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH
- (2018) A. A. Khorana et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
- (2018) Sonia S Anand et al. LANCET
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of apixaban versus warfarin in patients with end-stage renal disease: Meta-analysis
- (2018) Ronpichai Chokesuwattanaskul et al. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017
- (2018) Junya Zhu et al. PHARMACOTHERAPY
- Benefit, risk and cost of new oral anticoagulants and warfarin in atrial fibrillation; A multicriteria decision analysis
- (2018) Jose Mendoza-Sanchez et al. PLoS One
- Nonvitamin K Antagonist Oral Anticoagulants Use in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves/Prior Surgical Valve Repair: A Multicenter Clinical Practice Experience
- (2018) Emilio Attena et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Evidence Gaps in the Era of Non–Vitamin K Oral Anticoagulants
- (2018) Konstantinos N. Aronis et al. Journal of the American Heart Association
- Direct Oral Anticoagulant Agents: Pharmacologic Profile, Indications, Coagulation Monitoring, and Reversal Agents
- (2018) Deborah K. Rose et al. Journal of Stroke & Cerebrovascular Diseases
- Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation
- (2018) Kazuhiko Kido et al. ANNALS OF PHARMACOTHERAPY
- Antithrombotic Therapy for Atrial Fibrillation
- (2018) Gregory Y.H. Lip et al. CHEST
- Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
- (2018) Dominick J. Angiolillo et al. CIRCULATION
- Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCI
- (2018) Gregory Y H Lip et al. EUROPEAN HEART JOURNAL
- Anticoagulation at the extremes of body weight: choices and dosing
- (2018) Georgia J. B. McCaughan et al. Expert Review of Hematology
- Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
- (2018) Marc Carrier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry
- (2017) Martín Ruiz Ortiz et al. EUROPACE
- Body mass index is an independent predictor of major bleeding in non-valvular atrial fibrillation patients taking dabigatran
- (2017) Chen-Hung Lee et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease
- (2017) Giulia Renda et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation
- (2017) John U. Doherty et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction
- (2017) Xiaoxi Yao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparative effectiveness of venous thromboembolism prophylaxis options for the patient undergoing total hip and knee replacement: a network meta-analysis
- (2017) A. Kapoor et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta-analysis
- (2017) K. Boonyawat et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- (2017) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
- (2017) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know
- (2017) Susan E. Conway et al. PHARMACOTHERAPY
- The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale
- (2017) Alex Spyropoulos et al. THROMBOSIS AND HAEMOSTASIS
- Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 TrialClinical Perspective
- (2016) Erin A. Bohula et al. CIRCULATION
- Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy
- (2016) Muthiah Vaduganathan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
- (2016) Glenn N. Levine et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH
- (2016) K. Martin et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
- (2016) C. Michael Gibson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients
- (2016) Alexander T. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients
- (2016) Anuj Shah et al. STROKE
- Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study
- (2016) André Rodrigues Durães et al. Drugs in research & development
- Efficacy and safety of novel oral anticoagulants in patients with bioprosthetic valves
- (2015) Ajay Yadlapati et al. Clinical Research in Cardiology
- Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer
- (2015) Agnes Y. Y. Lee et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
- (2014) Craig T. January et al. CIRCULATION
- Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants
- (2014) Adam Cuker et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rivaroxaban presents a better pharmacokinetic profile than dabigatran in an obese non-diabetic stroke patient
- (2014) Apostolos Safouris et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects
- (2013) Vijay V. Upreti et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis
- (2013) T. van der Hulle et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Ischemic Stroke in an Obese Patient Receiving Dabigatran
- (2013) Lorenz Breuer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
- (2013) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Apixaban for the Treatment of Acute Venous Thromboembolism
- (2013) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation
- (2013) Amanda R. Harrington et al. STROKE
- Antithrombotic and Thrombolytic Therapy for Valvular Disease
- (2012) Richard P. Whitlock et al. CHEST
- Model-based Dose Selection for Phase III Rivaroxaban Study in Japanese Patients with Non-valvular Atrial Fibrillation
- (2012) Takahiko Tanigawa et al. Drug Metabolism and Pharmacokinetics
- Apixaban for Extended Treatment of Venous Thromboembolism
- (2012) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
- (2011) Sidney C. Smith et al. CIRCULATION
- Aspirin
- (2011) Valentin Fuster et al. CIRCULATION
- Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial
- (2011) K.-H. LIESENFELD et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Bleeding With Single, Dual, or Triple Therapy With Warfarin, Aspirin, and Clopidogrel in Patients With Atrial Fibrillation
- (2010) Morten L. Hansen et al. ARCHIVES OF INTERNAL MEDICINE
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now